About Callus Company
Callus Company is a company based in Seongnam-si (South Korea) founded in 2022 by Ryan Kim, Juno Yu, and Bae Gyu-Jin. Callus Company offers products and services including SPRINT PROGRAM and Talent Matching Service. Callus Company operates in a competitive market with competitors including NeuroKaire, Manus Neuro, Luciole Medical, Rhaeos and RetiSpec, among others.
- Headquarter Seongnam-si, South Korea
- Founders Ryan Kim, Juno Yu, Bae Gyu-Jin
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Callus Company Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Callus Company
Callus Company offers a comprehensive portfolio of products and services, including SPRINT PROGRAM and Talent Matching Service.
Platform for matching students and companies for remote internships.
Service providing data-driven intern selection and evaluation.
Funding Insights of Callus Company
Investors in Callus Company
Callus Company has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include YL Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
YL Ventures is engaged in funding and supporting cybersecurity startups.
|
Locked | Locked | Locked |
Investor details for Callus Company
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Callus Company
Investment portfolio details for Callus Company
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Callus Company
Detailed financials for Callus Company
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Callus Company Comparisons
Peer comparison for Callus Company
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Callus Company
Callus Company operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuroKaire, Manus Neuro, Luciole Medical, Rhaeos and RetiSpec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Platform offering personalized treatment for psychiatric and neurological conditions
|
|
| Locked | Locked | Locked |
Devices for neuromotor impairment biomarkers are provided.
|
|
| Locked | Locked | Locked |
Brain monitoring devices and analytics platforms are developed and provided.
|
|
| Locked | Locked | Locked |
Noninvasive device developed for CSF monitoring and hydrocephalus management.
|
|
| Locked | Locked | Locked |
Non-invasive eye scanner for early Alzheimer’s detection is developed.
|
|
| Locked | Locked | Locked |
Brain activity data is analyzed digitally for medical providers.
|
Detailed competitors of Callus Company
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Callus Company
Complete news archive for Callus Company
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Callus Company
Callus Company was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Callus Company is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
Ryan Kim is the current CEO of Callus Company. They have also founded this company.
Founded in 2022 and based in Seongnam-si, South Korea, the company operates in the healthcare technology sector. Raw data is extracted and converted into digital biomarkers to assist in identifying early mild cognitive impairment by healthcare professionals. An app named The Golden Brain is offered, featuring daily puzzle games focused on memorization, calculation, coordination, and analysis to support brain training.
Callus Company's top competitors include NeuroKaire, Brain.Space and RetiSpec.
Callus Company offers SPRINT PROGRAM and Talent Matching Service.
Callus Company has 1 investor. Key investors include YL Ventures.